Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TACE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07009470
What this trial is testing

A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

Who this might be right for
HCC
Tongji Hospital 130
Testing effectiveness (Phase 2)UnknownNCT03511703
What this trial is testing

The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 40
Testing effectiveness (Phase 2)Ended earlyNCT02994251
What this trial is testing

A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Yale University 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Large-scale testing (Phase 3)Looking for participantsNCT05613478
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapyPreoperative
The First Affiliated Hospital with Nanjing Medical University 130
Not applicableStudy completedNCT03698643
What this trial is testing

Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization

Who this might be right for
Hepatic Tumor
University Hospital, Montpellier 145
Testing effectiveness (Phase 2)Ended earlyNCT01539018
What this trial is testing

Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE

Who this might be right for
Advanced Hepatocellular Carcinoma
Egyptian Society of Liver Cancer 77
Large-scale testing (Phase 3)UnknownNCT02338297
What this trial is testing

Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

Who this might be right for
Carcinoma, Hepatocellular
Nanjing Medical University 236
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Large-scale testing (Phase 3)UnknownNCT03338647
What this trial is testing

SBRT or TACE for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
University of Aarhus 180
Not applicableStudy completedNCT04975932
What this trial is testing

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 826
Not applicableStudy completedNCT05545046
What this trial is testing

Predictive Model for Pain After TACE

Who this might be right for
Hepatocellular Carcinoma
Yantai Yuhuangding Hospital 228
Not applicableUnknownNCT06607120
What this trial is testing

Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 950
Not applicableNot Yet RecruitingNCT06823050
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 59
Large-scale testing (Phase 3)UnknownNCT05344924
What this trial is testing

TACE Combined With Penpulimab and Anlotinib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 109
Large-scale testing (Phase 3)UnknownNCT03642561
What this trial is testing

Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE

Who this might be right for
Hepatocellular Carcinoma
Fudan University 300
Large-scale testing (Phase 3)UnknownNCT05472896
What this trial is testing

TACE With Dicycloplatin(TP21) in Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Gao-jun Teng 332
Testing effectiveness (Phase 2)Active Not RecruitingNCT04522544
What this trial is testing

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT05718232
What this trial is testing

SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University 136
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Next Page